Frontiers in Medicine (Apr 2022)

Case Report and Literature Review: Behçet’s Disease With a Novel TFPI Gene Mutation

  • Jiewen Ma,
  • Wengang Sun,
  • Liang Tang,
  • Di Yang

DOI
https://doi.org/10.3389/fmed.2022.873600
Journal volume & issue
Vol. 9

Abstract

Read online

We report a case of Behçet’s disease (BD) with a newly identified tissue factor pathway inhibitor (TFPI) gene mutation. The patient suffered from recurrent deep vein thrombosis and dural sinus thrombosis which could not be relieved by constant anticoagulation therapy. Slight relapsing oral lesion was the initial manifestation of BD but was neglected. Genital ulcers and ocular symptoms were manifest 8-month later than vascular involvement. The patient was diagnosed with BD at last and a novel mutation in TFPI was identified simultaneously. After administration with azathioprine and dexamethasone, the clinical symptoms were quickly gone and no relapse was found during 7-month follow-up.

Keywords